Gabapentin augmentation therapy in bipolar depression

Bipolar Disorders

Volumn 4, Issue 5, 2002, Pages 296-301

  Wang, Po W ^a   Santosa, Claudia ^a   Schumacher, Matthew ^a   Winsberg, Mirène E ^a   Strong, Connie ^a   Ketter, Terence A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar affective disorder; Depression; Gabapentin

Indexed keywords

CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPOMANIA; MALE; MOOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; RATING SCALE; SEDATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; WEIGHT GAIN;

ACETIC ACIDS; ADULT; AMINES; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLOZAPINE; CYCLOHEXANECARBOXYLIC ACIDS; DRUG THERAPY, COMBINATION; FEMALE; GAMMA-AMINOBUTYRIC ACID; HUMANS; LITHIUM CARBONATE; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 0036788921     PISSN: 13985647     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-5618.2002.01211.x     Document Type: Article

References (44)

1. Fieve RR, Platman SR, Plutchik RR. The use of lithium in affective disorders. I. Acute endogenous depression. Am J Psychiatry 1968; 125: 487-491.
2. Goodwin FK, Murphy DL, Bunney WE Jr. Lithium-carbonate treatment in depression and mania. A longitudinal double-blind study. Arch Gen Psychiatry 1969; 21: 486-496.
3. Stokes PE, Shamoian CA, Stoll PM, Patton MJ. Efficacy of lithium as acute treatment of manic-depressive illness. Lancet 1971; 1: 1319 1325.
4. Noyes R Jr, Dempsey GM, Blum A, Cavanaugh GL. Lithium treatment of depression. Compr Psychiatry 1974; 15: 187-193.
5. Mendels J. Lithium in the treatment of depression. Am J Psychiatry 1976; 133: 373-378.
6. Baron M, Gershon ES, Rudy V, Jonas WZ, Buchsbaum M. Lithium carbonate response in depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry 1975; 32: 1107-1111.
7. Donnelly EF, Goodwin FK, Waldman IN, Murphy DL. Prediction of antidepressant responses to lithium. Am J Psychiatry 1978; 135: 552-556.
8. Greenspan K, Schildkraut JJ, Gordon EK, Baer L, Aronoff MS, Durell J. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. J Psychiatr Res 1970; 7: 171-183.
9. Bowden CL, Calabrese JR, McElroy SL et al. A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen. Psychiatry 2000; 57: 481-489.
10. Davis LL, Kabel D, Patel D et al. Valproate as an antidepressant in major depressive disorder. Psychopharmacol Bull 1996; 32: 647-652.
11. Winsberg ME, DeGolia SG, Strong CM, Ketter TA. Divalproex therapy in medication-naive and mood-stabilizer-naive bipolar II depression. J Affect Disord 2001; 67: 207-212.
12. Post RM, Uhde TW, Roy-Byrne PP, Joffe RT. Anti-depressant effects of carbamazepine. Am J Psychiatry 1986; 143: 29-34.
13. Small JG. Anticonvulsants in affective disorders. Psychopharmacol Bull 1990; 26: 25-36.
14. Post RM, Leverich GS, Rosoff AS, Altshuler LL. Carbamazepine prophylaxis in refractory affective disorders: a focus on long-term follow-up. J Clin Psychopharmacol 1990; 10: 318-327.
15. Ballenger JC, Post RM. Carbamazepine in manic-depressive illness: a new treatment. Am J Psychiatry 1980; 137: 782-790.
16. Okuma T, Inanaga K, Otsuki S et al. A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology 1981; 73: 95-96.
17. Post RM, Uhde TW, Rubinow DR, Huggins T. Differential time course of antidepressant effects after sleep deprivation, ECT, and carbamazepine: clinical and theoretical implications. Psychiatry Res 1987; 22: 11-19.
18. Altshuler LL, Post RM, Leverich GS, Mikalauskas K, Rosoff A, Ackerman L. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995; 152: 1130-1138.
19. Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd G.D. A double-blind placebo-cotrolled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999; 60: 79-88.
20. Calabrese JR, Suppes T, Bowden CL et al. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 2000; 61: 841-850.
21. Frye MA, Ketter TA, Kimbrell TA et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000; 20: 607-614.
22. Petroff OA, Rothman DL, Behar KL, Lamoureux D, Mattson RH. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Ann Neurol 1996; 39: 95-99.
23. Pande AC, Davidson JR, Jefferson JW et al. Treatment of social phobia with gabapentin: a placebo-controlled study. J Clin Psychopharmacol 1999; 19: 341-348.
24. Pande AC, Pollack MH, Crockatt J et al. Placebo-controlled study of gabapentin treatment of panic disorder. J Clin Psychopharmacol 2000; 20: 467-471.
25. Marcotte DB, Fogleman L, Wolfe N, Nemire R. Gabapentin: an effective therapy for patients with bipolar affective disorder. 150th Annual Meeting of the American Psychiatric Association, San Diego, May 17-22, 1997.
26. Pande AC, Crockatt JG, Janney CA, Werth JL, Tsaroucha G. Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group. Bipolar Disord 2000; 2 (3 Part 2): 249-255.
27. Yasmin S, Carpenter LL, Leon Z, Siniscalchi JM, Price LH. Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review. J Affect Disord 2001; 63: 243-247.
28. Vieta E, Martinez-Aran A, Nieto E et al. Adjunctive gabapentin treatment of bipolar disorder. Eur Psychiatry 2000; 15: 433-437.
29. Altshuler LL, Keck PE, McElroy SL, Suppes T, Brown ES, Denicoff K. Gabapentin in the acute treatment of refractory bipolar disorder. Bipolar Disorders 1999; 1: 61-65.
30. Young LT, Robb J, Patelis-Siotis I, MacDonald C, Joffe RT. Gabapentin in bipolar depression: a case series. 150th Annual Meeting of the American Psychiatric Association, San Diego, May 17-22, 1997.
31. Ghaemi SN, Goodwin FK. Gabapentin treatment of the non-refractory bipolar spectrum: an open case series. J Affect Disord 2001; 65: 167-171.
32. Perugi G, Toni C, Ruffolo G, Sartini S, Simonini E, Akiskal H. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states. Pharmacopsychiatry 1999; 32: 136-141.
33. Guille C, Demopulos CM, Shriver AE, Sachs GS. Gabapentin versus placebo as adjunctive treatment for acute mania and mixed states in bipolar disorder. 152nd Annual Meeting of the American Psychiatric Association, Washington, May 15-20, 1999.
34. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 12: 56-62.
35. Zitman FG, Mennen MF, Griez E, Hooijer C. The different versions of the Hamilton Depression Rating Scale. Psychopharmacol Ser 1990; 9: 28-34.
36. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
37. Guy We. ECDEU Assessment Manual for Psychopharmacology, Revised. DHEW Publication No. ADM 76-338. Rockville, MD: US Department of Health, Education, and Welfare, 1976.
38. Young LT. An open trial of gabapentin in bipolar disorder. 151st Annual Meeting of the American Psychiatric Association, Toronto, May 30-June 4, 1998.
39. Obrocea GV, Dunn RM, Frye MA et al. Clinical predictors of response to lamotrigine and gabapentin mono-therapy in refractory affective disorders. Biol Psychiatry 2000 (in press).
40. Petty F. GABA and mood disorders: a brief review and hypothesis. J Affect Disord 1995; 34: 275-281.
41. Sanacora G, Mason GF, Rothman DL et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999; 56: 1043-1047.
42. Short C, Cooke L. Hypomania induced by gabapentin. Br J Psychiatry 1995; 166: 679-680.
43. Leweke FM, Bauer J, Elger CE. Manic episode due to gabapentin treatment. Br J Psychiatry 1999; 175: 291.
44. Young LT, Joffe RT, Robb JC, MacQueen GM, Marriott M, Patelis-Siotis I. Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression. Am J Psychiatry 2000; 157: 124-126.